González-Méijome José M, Carracedo Gonzalo, Lopes-Ferreira Daniela, Faria-Ribeiro Miguel A, Peixoto-de-Matos Sofia C, Queirós António
Clinical and Experimental Optometry Research Lab. Center of Physics, University of Minho, Braga, Portugal.
Clinical and Experimental Optometry Research Lab. Center of Physics, University of Minho, Braga, Portugal.
Cont Lens Anterior Eye. 2016 Feb;39(1):72-7. doi: 10.1016/j.clae.2015.06.009. Epub 2015 Jul 15.
To describe the stabilization of early adult-onset myopia in three university students after initiating orthokeratology treatment with corneal refractive therapy contact lenses.
Three Caucasian early adult-onset progressing myopic subjects (1 male, 2 females) were fitted with corneal refractive therapy lenses to correct myopia between -1.50 and -2.50 D of sphere using Paragon CRT (Paragon Vision Sciences, Mesa, AZ) lenses for overnight orthokeratology. The pre-treatment refractive history from 2005 as well as refraction and axial length after treatment onset are reported over a period of 3 years between December 2009 and January 2013 with an additional year of follow-up after treatment discontinuation (January-December 2013). The peripheral refractive patterns and topographic changes are also reported individually.
Treatment was successful in all three subjects achieving uncorrected visual acuity of 20/20 or better monocularly. During a period of 3 years of follow-up the subjects did not experience progression in their refractive error, nor in their axial length (measured during the last 2 years of treatment and 1 year after discontinuation). Furthermore, the subjects recovered to their baseline refraction and did not progressed further over the following year after lens wear discontinuation.
We cannot attribute a causative effect to the orthokeratology treatment alone as underlying mechanism for myopia stabilization in this 3 patients. However, the present report points to the possibility of stabilization of early adult-onset myopia progression in young adults using corneal refractive therapy treatment.
描述三名大学生在开始使用角膜屈光治疗隐形眼镜进行角膜塑形术治疗后,早发性成人近视的稳定情况。
三名白种人早发性进行性近视受试者(1名男性,2名女性)佩戴角膜屈光治疗镜片,使用Paragon CRT(Paragon Vision Sciences,亚利桑那州梅萨)镜片进行夜间角膜塑形术,以矫正-1.50至-2.50 D球镜度的近视。报告了2005年的治疗前屈光史以及2009年12月至2013年1月的3年期间治疗开始后的验光和眼轴长度,治疗停止后还进行了额外一年的随访(2013年1月至12月)。还分别报告了周边屈光模式和地形变化。
所有三名受试者的治疗均成功,单眼裸眼视力达到20/20或更好。在3年的随访期间,受试者的屈光不正和眼轴长度均未进展(在治疗的最后2年和停止治疗后1年测量)。此外,受试者恢复到基线验光状态,在停止佩戴镜片后的次年没有进一步进展。
我们不能将角膜塑形术治疗单独归因于这3例患者近视稳定的潜在机制。然而,本报告指出了使用角膜屈光治疗在年轻成年人中稳定早发性成人近视进展的可能性。